Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.
The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Depressive Disorders market in Nigeria has seen significant growth in recent years, driven by a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in Nigeria have been shifting towards a greater awareness and acceptance of mental health issues, including depressive disorders. This has led to an increased demand for treatment options and therapies. Additionally, there has been a growing preference for holistic approaches to mental health, including alternative therapies and lifestyle changes. Customers are seeking out natural remedies and non-pharmaceutical interventions to complement traditional treatments.Trends in the market have also contributed to the growth of the Depressive Disorders market in Nigeria. The increasing availability of mental health services, including counseling and therapy, has made it easier for individuals to seek help for their depressive disorders. This has resulted in a higher diagnosis rate and a larger customer base for treatment options. Furthermore, advancements in technology have made it possible for individuals to access mental health resources online, providing greater convenience and accessibility.Local special circumstances in Nigeria have played a role in the development of the Depressive Disorders market. Nigeria has a large population, with a significant portion of the population experiencing high levels of stress and anxiety due to various factors such as economic instability, political unrest, and social challenges. These circumstances have contributed to an increased prevalence of depressive disorders, creating a greater need for treatment options and therapies.Underlying macroeconomic factors have also influenced the growth of the Depressive Disorders market in Nigeria. The country has experienced economic growth in recent years, resulting in a rising middle class with increased disposable income. This has allowed more individuals to afford mental health treatments and therapies. Additionally, the government has recognized the importance of mental health and has taken steps to improve access to mental health services, further driving the growth of the market.In conclusion, the Depressive Disorders market in Nigeria has experienced significant growth due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The increasing awareness and acceptance of mental health issues, along with the availability of mental health services and advancements in technology, have created a greater demand for treatment options. The local special circumstances in Nigeria, such as a large population and high levels of stress and anxiety, have contributed to the growth of the market. Furthermore, underlying macroeconomic factors, including economic growth and government support, have played a role in driving the development of the market.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights